Monoclonal antibodies against the RGM a protein and uses thereof

Details for Australian Patent Application No. 2009218693 (hide)

Owner Abbott GmbH & Co. KG Abbott Laboratories

Inventors Schmidt, Martin; Muller, Bernhard K.; Hsieh, Chung-ming; Leddy, Mary R.; Bardwell, Phillip D.; Barlow, Eve H.

Agent Spruson & Ferguson

Pub. Number AU-A-2009218693

PCT Pub. Number WO2009/106356

Priority 61/032,707 29.02.08 US; 61/090,743 21.08.08 US

Filing date 27 February 2009

Wipo publication date 3 September 2009

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/106356 Priority application(s): WO2009/106356

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009218694-Method and device for converting carbonaceous raw materials

2009218688-Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the B2 adrenergic receptor